Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Medical Research Center for Hematology is a leading Russian federal institution dedicated to the diagnosis and treatment of blood disorders, including various forms of leukemia, lymphoma, and hemophilia. It functions as a comprehensive hub for hematological research, clinical practice, and the development of new therapeutic protocols. The center operates specialized laboratories for molecular genetics, immunology, and bone marrow transplantation, serving as a primary site for complex hematological surgeries and stem cell therapies. In addition to clinical care, it oversees national standards for hematology and conducts extensive clinical trials for both domestic and international pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Hematology.